Bereich
Rheumatologie
RHEUMA · Dept. I
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility
González-Serna D, Boiardi L, Emmi G, Cimmino M, Vaglio A, Herrick A, Denton C, Salvarani C, Cid M, Morgan A, Fonseca C, González-Gay M, Martín J, Beretta L, Holle J, Neumann T, Carmona E, Ortego-Centeno N, Simeón C, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F, European GCA Consortium, European Scleroderma Group, Witte T, Márquez A. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility. PloS one 2018; 13:e0209343.
26.12.2018A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility
26.12.2018PloS one 2018; 13:e0209343
González-Serna David, Boiardi Luigi, Emmi Giacomo, Cimmino Marco A, Vaglio Augusto, Herrick Ariane L, Denton Christopher P, Salvarani Carlo, Cid María C, Morgan Ann W, Fonseca Carmen, González-Gay Miguel A, Martín Javier, Beretta Lorenzo, Holle Julia, Neumann Thomas, Carmona Elio G, Ortego-Centeno Norberto, Simeón Carmen P, Solans Roser, Hernández-Rodríguez José, Tolosa Carlos, Castañeda Santos, Narváez Javier, Martinez-Valle Ferran, European GCA Consortium, European Scleroderma Group, Witte Torsten, Márquez Ana
Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis
Neumann T, Martorana D, Moosig F, Ohlsson S, Quickert S, Ramirez S, Rewerska B, Schett G, Sinico R, Szczeklik W, Tesar V, Vukcevic D, Terrier B, Watts R, Vaglio A, Holle J, Wallace C, Little M, Leslie S, Lamprecht P, Lyons P, Peters J, Alberici F, Liley J, Coulson R, Astle W, Baldini C, Francesco B, Cid M, Elding H, Emmi G, Epplen J, Guillevin L, Jayne D, Jiang T, Gunnarsson I, Smith K. Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis. bioRxiv (The Preprint Server for Biology) 2018
10.12.2018Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis
10.12.2018bioRxiv (The Preprint Server for Biology) 2018
Neumann Thomas, Martorana Davide, Moosig Frank, Ohlsson Sophie, Quickert Stefanie, Ramirez Stefanie, Rewerska Barbara, Schett Georg, Sinico Renato A., Szczeklik Wojciech, Tesar Vladimir, Vukcevic Damjan, Terrier Benjamin, Watts Richard A, Vaglio Augusto, Holle Julia U, Wallace Chris, Little Mark A., Leslie Stephen, Lamprecht Peter, Lyons Paul A, Peters James E, Alberici Frederica, Liley James E, Coulson Richard M.R., Astle William, Baldini Chiara, Francesco Bonatti, Cid María C, Elding Heather, Emmi Giacomo, Epplen Jörg, Guillevin Loic, Jayne David R.W., Jiang Tao, Gunnarsson Iva, Smith Kenneth G.C.
[Vasculitides and eosinophilic pulmonary diseases]
Kroegel C, Foerster M, Quickert S, Slevogt H, Neumann T. [Vasculitides and eosinophilic pulmonary diseases]. Z Rheumatol 2018; 77:907-922.
01.12.2018[Vasculitides and eosinophilic pulmonary diseases]
01.12.2018Z Rheumatol 2018; 77:907-922
Kroegel C, Foerster M, Quickert S, Slevogt H, Neumann Thomas
Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation
Pirker I, Krane-Nuber J, Albrich W, Mueller R, Neumann T. Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation. BMC Rheumatology 2018; 2
03.11.2018Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation
03.11.2018BMC Rheumatology 2018; 2
Pirker Ian F J, Krane-Nuber Jacqueline, Albrich Werner, Mueller Ruediger B, Neumann Thomas
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]
Fiehn C, Kuipers J, Lorenz H, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony H, Wassenberg S, Wollenhaupt J, Krause A, Kellner H, Gromnica-Ihle E, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Krüger K. [S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]. Z Rheumatol 2018; 77:35-53.
01.08.2018[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]
01.08.2018Z Rheumatol 2018; 77:35-53
Fiehn C, Kuipers J, Lorenz H-M, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth Andrea, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony H-P, Wassenberg S, Wollenhaupt J, Krause A, Kellner H, Gromnica-Ihle E, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Krüger K
Extracraniale Riesenzellarteriitis mit kompliziertem Verlauf
Neumann T. Extracraniale Riesenzellarteriitis mit kompliziertem Verlauf - Special focus on Tocilizumab. Rheuma Schweiz 2018
23.07.2018Extracraniale Riesenzellarteriitis mit kompliziertem Verlauf
23.07.2018Rheuma Schweiz 2018
Neumann Thomas
The Value of an Automated Ultrasound System in the Detection of Synovitis
Mueller R, Grunke M, Wendler J, Schuch F, Hofmann-Preiss K, Boettger I, Jakobs R, Schulze-Koops H, von Kempis J. The Value of an Automated Ultrasound System in the Detection of Synovitis. Ultrasound Int Open 2018; 4:E61-E68.
11.07.2018The Value of an Automated Ultrasound System in the Detection of Synovitis
11.07.2018Ultrasound Int Open 2018; 4:E61-E68
Mueller Ruediger, Grunke Mathias, Wendler Jörg, Schuch Florian, Hofmann-Preiss Karina, Boettger Ina, Jakobs Rüdiger, Schulze-Koops Hendrik, von Kempis Johannes
Eosinophile Granulomatose und Polyangiitis – Diagnostik und Therapie
Kroegel C, Slevogt H, Foerster M, Ali R, Neumann T, Costabel U. Eosinophile Granulomatose und Polyangiitis – Diagnostik und Therapie. Der Pneumologe 2018; 5/2018
20.06.2018Eosinophile Granulomatose und Polyangiitis – Diagnostik und Therapie
20.06.2018Der Pneumologe 2018; 5/2018
Kroegel C, Slevogt H, Foerster M, Ali R, Neumann Thomas, Costabel U
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial
Genovese M, Meerwein S, Mohamed M, Zhou Y, Zhang Y, Rubbert-Roth A, Hall S, Combe B, Fleischmann R, Pangan A. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial. Lancet 2018; 391:2513-2524.
18.06.2018Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial
18.06.2018Lancet 2018; 391:2513-2524
Genovese Mark C, Meerwein Sebastian, Mohamed Mohamed-Eslam F, Zhou Yijie, Zhang Ying, Rubbert-Roth Andrea, Hall Stephen, Combe Bernard, Fleischmann Roy, Pangan Aileen L
Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort
Mueller R, Kaegi T, Haile S, Schulze-Koops H, Schiff M, von Kempis J. Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort. RMD Open 2018; 4:e000673.
06.06.2018Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort
06.06.2018RMD Open 2018; 4:e000673
Mueller Ruediger B, Kaegi Toni, Haile Sarah R, Schulze-Koops Hendrik, Schiff Michael, von Kempis Johannes
Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept
Popp F, Semela D, von Kempis J, Mueller R. Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept. BMJ Case Rep 2018; 2018
12.05.2018Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept
12.05.2018BMJ Case Rep 2018; 2018
Popp Florian, Semela David, von Kempis Johannes, Mueller Ruediger B
Anti-Interleukin-5-Therapie und eosinophile Granulomatose mit Polyangiitis
Kroegel C, Costabel U, Neumann T. Anti-Interleukin-5-Therapie und eosinophile Granulomatose mit Polyangiitis. Der Pneumologe 2018; 3/2018
27.03.2018Anti-Interleukin-5-Therapie und eosinophile Granulomatose mit Polyangiitis
27.03.2018Der Pneumologe 2018; 3/2018
Kroegel C, Costabel U, Neumann Thomas
Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort
Heinimann K, von Kempis J, Sauter R, Schiff M, Sokka-Isler T, Schulze-Koops H, Müller R. Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. J Clin Med 2018; 7
13.03.2018Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort
13.03.2018J Clin Med 2018; 7
Heinimann Katja, von Kempis Johannes, Sauter Rafael, Schiff Michael, Sokka-Isler Tuulikki, Schulze-Koops Hendrik, Müller Rüdiger
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
Rubbert-Roth A, Furst D, Nebesky J, Jin A, Berber E. A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases. Rheumatol Ther 2018; 5:21-42.
03.03.2018A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
03.03.2018Rheumatol Ther 2018; 5:21-42
Rubbert-Roth Andrea, Furst Daniel E, Nebesky Jan Michael, Jin Angela, Berber Erhan
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting
Alten R, Burkhardt H, Feist E, Krüger K, Rech J, Rubbert-Roth A, Voll R, Elbez Y, Rauch C. Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting. Arthritis Res Ther 2018; 20:1.
02.01.2018Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting
02.01.2018Arthritis Res Ther 2018; 20:1
Alten Rieke, Burkhardt Harald, Feist Eugen, Krüger Klaus, Rech Juergen, Rubbert-Roth Andrea, Voll Reinhard E, Elbez Yedid, Rauch Christiane
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
Rubbert-Roth A, Atzeni F, Masala I, Caporali R, Montecucco C, Sarzi-Puttini P. TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?. Autoimmun Rev 2018; 17:24-28.
01.01.2018TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
01.01.2018Autoimmun Rev 2018; 17:24-28
Rubbert-Roth Andrea, Atzeni F, Masala IF, Caporali R, Montecucco C, Sarzi-Puttini P
[A Rare Differential Diagnosis of Chronic Cough]
Dicker M, Schneider T, von Kempis J, Diethelm M. [A Rare Differential Diagnosis of Chronic Cough]. Dtsch Med Wochenschr 2017; 142:1751-1755.
16.11.2017[A Rare Differential Diagnosis of Chronic Cough]
16.11.2017Dtsch Med Wochenschr 2017; 142:1751-1755
Dicker Michael, Schneider Tino, von Kempis Johannes, Diethelm Markus
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
Rubbert-Roth A, Atzeni F, Masala I, Caporali R, Montecucco C, Sarzi-Puttini P. TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?. Autoimmun Rev 2017; 17:24-28.
03.11.2017TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
03.11.2017Autoimmun Rev 2017; 17:24-28
Rubbert-Roth Andrea, Atzeni Fabiola, Masala Ignazio Francesco, Caporali Roberto, Montecucco Carlomaurizio, Sarzi-Puttini Piercarlo
[51-year-old man with with acute coronary syndrome and bipulmonary infiltrates]
Michels G, Radtke A, Rubbert-Roth A, Pfister R, Quaas A. [51-year-old man with with acute coronary syndrome and bipulmonary infiltrates]. Dtsch Med Wochenschr 2017; 142:1545.
10.10.2017[51-year-old man with with acute coronary syndrome and bipulmonary infiltrates]
10.10.2017Dtsch Med Wochenschr 2017; 142:1545
Michels Guido, Radtke Anne, Rubbert-Roth Andrea, Pfister Roman, Quaas Alexander
Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp
Walker U, Müller R, Jaeger V, Theiler R, Forster A, Dufner P, Ganz F, Kyburz D. Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp. Rheumatology (Oxford) 2017; 56:1707-1712.
01.10.2017Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp
01.10.2017Rheumatology (Oxford) 2017; 56:1707-1712
Walker Ulrich, Müller Rüdiger, Jaeger Veronika, Theiler Robert, Forster Adrian, Dufner Patrick, Ganz Fabiana, Kyburz Diego